Project Grant HT94252510762
Award Date
9/1/25
Completion Date
8/31/29
Dollars Obligated
$669K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
New York, NY 10022, USA
Similar Awards
The Defense Health Agency has awarded a $1,387,727 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Sloan-Kettering Institute for Cancer Research. The grant, titled "Integrated Immunomodulatory Analysis of LAG3 Inhibition in Renal Cell Carcinoma", will fund research aimed at transforming healthcare for military service members, veterans, and the broader public. The research will investigate innovative approaches to cancer diagnosis,...
This federal Project Grant award of $1,356,000.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research aimed at the "Restoration of Clear Cell Renal Cell Carcinoma Tumorigenicity by Cell Reprogramming" at the Weill Medical College of Cornell University in New York, NY. The award, with a performance period from November 1, 2024 to October 31, 2028, will fund specialized biomedical research services focused on...
This federal Project Grant award of $708,000.00 provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research conducted by the Sloan-Kettering Institute for Cancer Research, a non-profit organization located in New York, NY. The research project is focused on investigating the "Prevalence and Biologic Impact of FGFR3 Genomic Alterations in Bladder Cancer". The 2-year award period runs from September 15, 2023 to...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,518,817.00 to Weill Medical College of Cornell University to characterize 3'-UTR biology as a mechanism of therapy response in high-risk prostate cancer. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical research in critical medical domains. The award has a...
This federal Project Grant award of $2,542,500.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research aimed at therapeutically targeting the tumor microenvironment in triple-negative breast cancer patients at high risk of relapse, as well as preclinical models of lung metastases. The award was granted to the Weill Medical College of Cornell University, a prestigious academic medical institution, with a performance...
The federal Project Grant award of $1,214,375.00 from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), is funding a research project led by Yale University. The project is investigating the use of decoy-resistant IL-18 and immune checkpoint inhibitors in preclinical murine and ex vivo patient-derived models of renal cell carcinoma. The award began on September 15, 2024 and is set to conclude on September 14, 2028. The Military Medical Research...
This federal Project Grant award for $704,000.00, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research by the Sloan-Kettering Institute for Cancer Research in New York, NY. The research aims to investigate the role of the NF-I/A transcription factor in regulating fatty acid metabolism in kidney cancer. This multi-year project will run from September 1, 2024 to August 31, 2028. As the prime grantee, the Sloan-Kettering...
The Department of Defense's Defense Health Agency awarded a $700,032 Project Grant to Duke University under the Military Medical Research and Development (CFDA 12.420) program. The grant, effective August 1, 2025 through July 31, 2029, will fund research to investigate "Imaging Strategies and Biomarkers for Detecting the Metabolic Interplay of Glutamine and Aspartate in RCC." This research aims to transform healthcare for military service members, veterans, and the broader public by...
The Defense Health Agency awarded a $176,000 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Sloan-Kettering Institute for Cancer Research in New York. The grant, titled "UNRAVELING THE INTERACTIONS OF MITOCHONDRIALLY ENCODED COMPLEX I MUTATIONS WITH HYPOXIA AND ANTITUMOR IMMUNE RESPONSE IN CHROMOPHOBE RENAL CELL CARCINOMA", will support advanced biomedical research aimed at transforming healthcare for military service members, veterans,...
This Project Grant award, valued at $312,610.00, was issued on September 30, 2024 by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The purpose of the award is to support research on the "Role of Functional Factors in AR Reprogramming and Progression of Prostate Cancer" at the Weill Medical College of Cornell University in New York, NY. The award has a period of performance from September 30, 2024 to September 29, 2026. This...